Cargando…
I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
TVP1022, the S-enantiomer of rasagiline (Azilect®) (N-propargyl-1R-aminoindan), exerts cyto/cardio-protective effects in a variety of experimental cardiac and neuronal models. Previous studies have demonstrated that the protective activity of TVP1022 and other propargyl derivatives involve the activ...
Autores principales: | Barac, Yaron D., Bar-Am, Orit, Liani, Esti, Amit, Tamar, Frolov, Luba, Ovcharenko, Elena, Angel, Itzchak, Youdim, Moussa B. H., Binah, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499525/ https://www.ncbi.nlm.nih.gov/pubmed/23166584 http://dx.doi.org/10.1371/journal.pone.0047890 |
Ejemplares similares
-
Correction: I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
por: Barac, Yaron D., et al.
Publicado: (2013) -
The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats
por: Malka, Assaf, et al.
Publicado: (2016) -
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013) -
2-Imidazoline Nitroxide Derivatives of Cymantrene
por: Maryunina, Kseniya, et al.
Publicado: (2022) -
Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008)